Virusul Epstein-Barr – cauze și simptome - Cancer360
Frontiers | Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study
Cureus | Secondary Immune Thrombocytopenic Purpura Due to Primary Epstein- Barr Virus Infection
Profil serologic virus Epstein Barr. Analize medicale
Frontiers | Epstein-Barr Virus and Neurological Diseases
VIDAS EBV panel | bioMérieux
PLATELIA™ EB-NA-1 IgG
Anticorpi anti virus Epstein-Barr (EBV) - Analisi Papagni
Virus di Epstein-Barr - Euroimmun
Epstein Barr – simptomatologie și tratament – NewsMed.ro
Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region | Scientific Reports
Cosa vuol dire EBV VCA e perché riguarda la mononucleosi
BMFPs, a versatile therapeutic tool for redirecting a preexisting Epstein-Barr virus antibody response toward defined target cells | Science Advances
Severe Epstein–Barr virus infection in primary immunodeficiency and the normal host - Worth - 2016 - British Journal of Haematology - Wiley Online Library
Mononucleoza infecţioasă poate apărea la pacienţii de toate vârstele
Epstein-Barr Virus | Bio-Rad
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications
DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas: Molecular Therapy - Oncolytics
Epstein-Barr virus (EBV) seropositivity and median antibody levels in... | Download Table
Frontiers | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis
Recent advances in understanding Epstein-Barr virus | F1000Research
Frontiers | Impact of Epstein–Barr virus infection in patients with inflammatory bowel disease
Mononucleoza infectioasa sau "boala sarutului" - Synevo
Epstein–Barr virus and multiple sclerosis | Nature Reviews Microbiology
Ac Anti-Epstein Barr EBNA IgG, VCA IgG, VCA IgM | MedLife
Epstein–Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection | Cell Communication and Signaling | Full Text
